Pratima Kumari

InstitutionIndian Institute of Technology Roorkee
AddressIndia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in January 2021
    All Publications
    Bar chart showing 7 publications over 3 distinct years, with a maximum of 3 publications in 2020 and 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kumar S, Singh B, Kumari P, Kumar PV, Agnihotri G, Khan S, Kant Beuria T, Syed GH, Dixit A. Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. Comput Struct Biotechnol J. 2021; 19:1998-2017. PMID: 33841751.
      Citations: 2     
    2. Bandyopadhyay T, Sharma A, Kumari P, Maria A, Choudhary R. Possible Early Vertical Transmission of COVID-19 from an Infected Pregnant Female to Her Neonate: A Case Report. J Trop Pediatr. 2021 01 29; 67(1). PMID: 33221859.
      Citations: 2     Fields:    Translation:Humans
    3. Kumari P, Rothan HA, Natekar JP, Stone S, Pathak H, Strate PG, Arora K, Brinton MA, Kumar M. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses. 2021 Jan 19; 13(1). PMID: 33477869.
      Citations: 31     Fields:    Translation:Animals
    4. Kumari P, Toshniwal D. Impact of lockdown on air quality over major cities across the globe during COVID-19 pandemic. Urban Clim. 2020 Dec; 34:100719. PMID: 33083215.
      Citations: 20     
    5. Kumari P, Toshniwal D. Impact of lockdown measures during COVID-19 on air quality- A case study of India. Int J Environ Health Res. 2022 Mar; 32(3):503-510. PMID: 32543256.
      Citations: 25     Fields:    
    6. Rothan HA, Stone S, Natekar J, Kumari P, Arora K, Kumar M. The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells. Virology. 2020 08; 547:7-11. PMID: 32442105.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health